Oncology

Abruzzo, T; Abraham, K; Karani, KB; Geller, JI; Vadivelu, S; Racadio, JM; Zhang, B; Correa, ZM. Correlation of Technical and Adjunctive Factors with Quantitative Tumor Reduction in Children Undergoing Selective Ophthalmic Artery Infusion Chemotherapy for Retinoblastoma. American Journal of Neuroradiology. 2021; 42:354-361.

Ambady, P; Bagley, SJ; Blakeley, J; Brooks, T; Bussière, MR; Campian, JL; Chan, MD; Chukwueke, UN; Cramer, CK; Couture, DE; et al. Contributors List. Neuro-Oncology for the Clinical Neurologist. 2021.

Bartlett, AL; Romick-Rosendale, L; Nelson, A; Abdullah, S; Luebbering, N; Bartlett, J; Brusadelli, M; Palumbo, JS; Lake, K; Litts, B; et al. Tryptophan metabolism is dysregulated in individuals with Fanconi anemia. Blood Advances. 2021; 5:250-261.

Basile, NL; Chardon, ML; Peugh, J; Edwards, CS; Szulczewski, L; Morrison, CF; Nagarajan, R; El-Sheikh, A; Chaney, JM; Pai, AL H; et al. Relationship Between Caregiver Uncertainty, Problem-Solving, and Psychological Adjustment in Pediatric Cancer. Journal of Pediatric Psychology. 2021; 46:1258-1266.

Bedard, MC; Brusadelli, MG; Carlile, A; Ruiz-Torres, S; Lodin, H; Lee, D; Kofron, M; Lambert, PF; Lane, A; Ameziane, N; et al. Patient-Derived Organotypic Epithelial Rafts Model Phenotypes in Juvenile-Onset Recurrent Respiratory Papillomatosis. Viruses. 2021; 13.

Bedard, MC; de Alarcon, A; Kou, YF; Lee, D; Sestito, A; Duggins, AL; Brusadelli, M; Lane, A; Wikenheiser-Brokamp, KA; Wells, SI; et al. HPV Strain Predicts Severity of Juvenile-Onset Recurrent Respiratory Papillomatosis with Implications for Disease Screening. Cancers. 2021; 13.

Blakeley, J; Langmead, S; de Blank, P. Chapter 16 Approach to patients with the neoplasms associated with neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis. Neuro-Oncology for the Clinical Neurologist. 2021.

Bondoc, A; Glaser, K; Jin, K; Lake, C; Cairo, S; Geller, J; Tiao, G; Aronow, B. Identification of distinct tumor cell populations and key genetic mechanisms through single cell sequencing in hepatoblastoma. Communications Biology. 2021; 4.

Breese, EH; Krupski, C; Nelson, AS; Perentesis, JP; Phillips, CL. Use of CD19-directed CAR T-Cell Therapy in an Infant With Refractory Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology. 2021; 43:152-154.

Brohl, AS; Sindiri, S; Wei, JS; Milewski, D; Chou, HC; Song, YK; Wen, X; Kumar, J; Reardon, HV; Mudunuri, US; et al. Immuno-transcriptomic profiling of extracranial pediatric solid malignancies. Cell Reports. 2021; 37.

Chaney, KE; Perrino, MR; Kershner, LJ; Patel, AV; Wu, J; Choi, K; Rizvi, TA; Dombi, E; Szabo, S; Largaespada, DA; et al. Cdkn2a Loss in a Model of Neurofibroma Demonstrates Stepwise Tumor Progression to Atypical Neurofibroma and MPNST. Cancer Research. 2021; 80:4720-4730.

Chang, EK; Chanson, D; Teh, JB; Iukuridze, A; Peng, K; Forman, SJ; Nakamura, R; Wong, FL; Cai, LY; Armenian, SH. Atrial Fibrillation in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation. Journal of Clinical Oncology. 2021; 39:902-910.

Chang, EK; Smith-Cohn, MA; Tamrazi, B; Ji, J; Krieger, M; Holdhoff, M; Eberhart, CG; Margol, AS; Cotter, JA. IDH-mutant brainstem gliomas in adolescent and young adult patients: Report of three cases and review of the literature. Brain Pathology. 2021; 31.

Coltin, H; Sundaresan, L; Smith, KS; Skowron, P; Massimi, L; Eberhart, CG; Schreck, KC; Gupta, N; Weiss, WA; Tirapelli, D; et al. Subgroup and subtype-specific outcomes in adult medulloblastoma. Acta Neuropathologica. 2021; 142:859-871.

Cooke-Barber, J; Scorletti, F; Rymeski, B; Eshelman-Kent, D; Nagarajan, R; Burns, K; Jenkins, T; Dasgupta, R. Long-term follow-up of surgical outcomes for patients with Wilms tumor and neuroblastoma. Cancer. 2021; 127:3232-3238.

Crotty, E; Downey, K; Ferrerosa, L; Flores, C; Hegde, B; Raskin, S; Hwang, E; Vitanza, N; Okada, H. Considerations when treating high-grade pediatric glioma patients with immunotherapy. Expert Review of Neurotherapeutics. 2021; 21:205-219.

Cunningham, S; McCauley, S; Vairamani, K; Speth, J; Girdhani, S; Abel, E; Sharma, RA; Perentesis, JP; Wells, SI; Mascia, A; et al. FLASH Proton Pencil Beam Scanning Irradiation Minimizes Radiation-Induced Leg Contracture and Skin Toxicity in Mice. Cancers. 2021; 13.

D’Souza, AM; Cast, A; Kumbaji, M; Rivas, M; Gulati, R; Johnston, M; Smithrud, D; Geller, J; Timchenko, N. Small Molecule Cjoc42 Improves Chemo-Sensitivity and Increases Levels of Tumor Suppressor Proteins in Hepatoblastoma Cells and in Mice by Inhibiting Oncogene Gankyrin. Frontiers in Pharmacology. 2021; 12.

Danziger-Isakov, L; Khalil, N; Divanovic, A; Frenck, R; Grimley, M; Iliopoulos, I; Marsh, R; Paulsen, G; Phillips, CL; Schulert, G; et al. Novel Treatment of Infant With COVID-19 With the Sialidase Fusion Protein, DAS181. Pediatric Infectious Disease Journal. 2021; 40:e234-e235.

DeWire, M; Erker, C; Hummel, TR; Chow, LM L; de Blank, P; Salloum, R; Pillay-Smiley, N; Hoffman, L; Gilger, E; Gallagher, M; et al. Overcoming barriers to establishing autopsy procurement programs in pediatric patients with central nervous system tumors: a call to develop regional centers. Journal of Neuro-Oncology. 2021; 152:107-114.

Emberesh, M; Rubinstein, JD; Young, J; Benoit, SW; Dandoy, CE; Weiss, BD. Tolerance of dinutuximab therapy for treatment of high-risk neuroblastoma in two patients with end-stage renal disease on dialysis. Pediatric Blood and Cancer. 2021; 68.

Frankart, AJ; Nagarajan, R; Pater, L. The impact of proton therapy on cardiotoxicity following radiation treatment. Journal of Thrombosis and Thrombolysis. 2021; 51:877-883.

Gardner, S; Koschmann, C; Tarapore, R; Allen, J; Zaky, W; Odia, Y; Hall, M; Daghistani, D; Khatib, Z; Aguilera, D; et al. CTNI-36. SAFETY OF ONC201 ADMINISTERED TWO CONSECUTIVE DAYS PER WEEK IN PEDIATRIC H3 K27M-MUTANT GLIOMA PATIENTS. Neuro-Oncology. 2021; 23:vi67-vi67.

Gracia-Maldonado, G; Clark, J; Burwinkel, M; Greenslade, B; Wunderlich, M; Salomonis, N; Leone, D; Gatti, E; Pierre, P; Kumar, AR; et al. LAMP-5 is an essential inflammatory-signaling regulator and novel immunotherapy target for Mixed Lineage Leukemia-Rearranged acute leukemia. Haematologica. 2021.

Graham, RT; Abu-Arja, MH; Stanek, JR; Cappellano, A; Coleman, C; Chi, S; Cooney, T; Dhall, G; Ellen, JG; Finlay, JL; et al. Multi-institutional analysis of treatment modalities in basal ganglia and thalamic germinoma. Pediatric Blood and Cancer. 2021; 68.

Graham, RT; Bell, EH; Webb, A; Zhao, Y; Timmers, C; Fleming, JL; Sells, BE; Robison, NJ; Palmer, JD; Finlay, JL; et al. Pediatric Gliosarcoma With and Without Neurofibromatosis Type 1: A Whole-exome Comparison of 2 Patients. Journal of Pediatric Hematology/Oncology. 2021; 43:e1201-e1204.

Graham, RT; Coven, SL; Stanek, JR; Folta, A; Hollingsworth, EW; Finlay, JL; Kumar, R. Venous thromboembolism in children with central nervous system tumors: Comparison of an institutional cohort to a national administrative database. Pediatric Blood and Cancer. 2021; 68.

Granger, MM; Naranjo, A; Bagatell, R; DuBois, SG; McCune, JS; Tenney, SC; Weiss, BD; Mosse, YP; Asgharzadeh, S; Grupp, SA; et al. Myeloablative Busulfan/Melphalan Consolidation following Induction Chemotherapy for Patients with Newly Diagnosed High-Risk Neuroblastoma: Children's Oncology Group Trial ANBL12P1. Transplantation and cellular therapy. 2021; 27:490.e1-490.e8.

Hegde, S; Gasilina, A; Wunderlich, M; Lin, Y; Buchholzer, M; Krumbach, OH F; Akbarzadeh, M; Ahmadian, MR; Seibel, W; Zheng, Y; et al. Inhibition of the RacGEF VAV3 by the small molecule IODVA1 impedes RAC signaling and overcomes resistance to tyrosine kinase inhibition in acute lymphoblastic leukemia. Leukemia. 2021.

Hitzler, J; Alonzo, T; Gerbing, R; Beckman, A; Hirsch, B; Raimondi, S; Chisholm, K; Viola, S; Brodersen, L; Loken, M; et al. High-dose AraC is essential for the treatment of ML-DS independent of postinduction MRD: results of the COG AAML1531 trial. Blood. 2021; 138:2337-2346.

Ibrahimova, A; Pommert, L; Breese, EH. Acute Leukemia in Infants. Current Oncology Reports. 2021; 23.

Janusz, JA; Klein-Tasman, BP; Payne, JM; Wolters, PL; Thompson, HL; Martin, S; de Blank, P; Ullrich, N; Del Castillo, A; Hussey, M; et al. Recommendations for Social Skills End Points for Clinical Trials in Neurofibromatosis Type 1. Neurology. 2021; 97:S73-S80.

Johnston, ME; Rivas, MP; Nicolle, D; Gorse, A; Gulati, R; Kumbaji, M; Weirauch, MT; Bondoc, A; Cairo, S; Geller, J; et al. Olaparib Inhibits Tumor Growth of Hepatoblastoma in Patient-Derived Xenograft Models. Hepatology. 2021; 74:2201-2215.

Jones, LM; Regan, C; Wolf, K; Bryant, J; Rakowsky, A; Pe, M; Snyder, DA. Effect of osteopathic manipulative treatment on pulmonary function testing in children with asthma. The Journal of the American Osteopathic Association. 2021; 121:589-596.

Jones, LM; Tarlock, K; Cooper, T. Targeted Therapy in Pediatric AML: An Evolving Landscape. Paediatric Drugs. 2021; 23:485-497.

Karkoska, K; Ricci, K; VandenHeuvel, K; Trout, AT; Smith, EA; Kotagal, M; Weiss, B. Metastatic neuroblastoma masquerading as infantile hemangioma in a 4-month-old child. Pediatric Blood and Cancer. 2021; 68.

Klein-Tasman, BP; Lee, K; Thompson, HL; Janusz, J; Payne, JM; Pardej, S; de Blank, P; Kennedy, T; Janke, KM; Castillo, AD; et al. Recommendations for Measurement of Attention Outcomes in Preschoolers With Neurofibromatosis. Neurology. 2021; 97:S81-S90.

Lake, CM; Bondoc, AJ; Dasgupta, R; Jenkins, TM; Towbin, AJ; Smith, EA; Alonso, MH; Geller, JI; Tiao, GM. Indocyanine green is a sensitive adjunct in the identification and surgical management of local and metastatic hepatoblastoma. Cancer Medicine. 2021; 10:4322-4343.

Lazow, M; Nievelstein, M; Lane, A; Bandopadhayay, P; DeWire-Schottmiller, M; Fouladi, M; Glod, J; Greiner, R; Hoffman, L; Hummel, T; et al. NIMG-11. VOLUMETRIC ENDPOINTS IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG): COMPARISON TO CROSS-SECTIONAL MEASURES AND CORRELATION WITH OUTCOMES. Neuro-Oncology. 2021; 23:vi129-vi130.

Lazow, MA; Lawson, SA; Salloum, R; Hummel, TR; Pillay Smiley, N; Dewire-Schottmiller, MD; Fouladi, M; De Blank, P. Trametinib-associated Hyponatremia in a Child With Low-grade Glioma is Not Seen Following Treatment With Alternative MEK Inhibitor. Journal of Pediatric Hematology/Oncology. 2021; 43:e550-e553.

Lee, A; Sun, L; Mochizuki, A; Reynoso, J; Orpilla, J; Chow, F; Kienzler, J; Everson, R; Nathanson, D; Liau, L; et al. IMMU-41. NEOADJUVANT PD-1 BLOCKADE INDUCES T CELL AND CDC1 ACTIVATION BUT FAILS TO OVERCOME THE IMMUNOSUPPRESSIVE TUMOR ASSOCIATED MACROPHAGES IN RECURRENT GLIOBLASTOMA. Neuro-Oncology. 2021; 23:vi101-vi101.

Lee, AH; Sun, L; Mochizuki, AY; Reynoso, JG; Orpilla, J; Chow, F; Kienzler, JC; Everson, RG; Nathanson, DA; Bensinger, SJ; et al. Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma. Nature Communications. 2021; 12.

Levine, JE; Grupp, SA; Pulsipher, MA; DIetz, AC; Rives, S; Myers, GD; August, KJ; Verneris, MR; Buechner, J; Laetsch, TW; et al. Pooled safety analysis of tisagenlecleucel in children and young adults with B cell acute lymphoblastic leukemia. Journal for ImmunoTherapy of Cancer. 2021; 9.

Lin, S; Larrue, C; Scheidegger, NK; Seong, BK A; Dharia, NV; Kuljanin, M; Wechsler, CS; Kugener, G; Robichaud, AL; Conway, AS; et al. An In Vivo CRISPR Screening Platform for Prioritizing Therapeutic Targets in AML. Cancer Discovery. 2021.

Luebbering, N; Abdullah, S; Lounder, D; Lane, A; Dole, N; Rubinstein, J; Hewison, M; Gloude, N; Jodele, S; Perentesis, KM R; et al. Endothelial injury, F-actin and vitamin-D binding protein after hematopoietic stem cell transplant and association with clinical outcomes. Haematologica. 2021; 106:1321-1329.

Ly, I; Hirbe, A; Jordan, J; Michaels, O; Kwon, D; Borcherding, D; Srihari, D; Dombi, E; Widemann, B; Pollard, K; et al. INNV-04. A MULTI-INSTITUTIONAL CLINICAL AND MRI REPOSITORY OF NEUROFIBROMATOSIS TYPE 1-ASSOCIATED PERIPHERAL NERVE SHEATH TUMORS. Neuro-Oncology. 2021; 23:vi105-vi106.

Ly, I; Liu, T; Cai, W; Kwon, D; Michaels, O; Bredella, M; Jordan, J; Dombi, E; Widemann, B; Hirbe, A; et al. NIMG-08. A MULTI-CENTER RADIOMICS-BASED MODEL TO DIFFERENTIATE BETWEEN NEUROFIBROMATOSIS TYPE 1-ASSOCIATED PLEXIFORM NEUROFIBROMAS AND MALIGNANT PERIPHERAL NERVE SHEATH TUMORS. Neuro-Oncology. 2021; 23:vi128-vi129.

McGrady, ME; Bredenberg, DL; Danziger-Isakov, L; Rios, J; Frias, O; West, MY; Fisher, P; Salloum, R; Pressey, JG; Norris, RE. Active and Protected: Developing a "Safer Sex " Handout for Adolescents and Young Adults with Cancer. Journal of Adolescent and Young Adult Oncology. 2021; 10:351-354.

Meijer, AJ M; Van Den Heuvel-Eibrink, MM; Brooks, B; Am Zehnhoff-Dinnesen, AG; Knight, KR; Freyer, DR; Chang, KW; Hero, B; Papadakis, V; Frazier, AL; et al. Recommendations for Age-Appropriate Testing, Timing, and Frequency of Audiologic Monitoring During Childhood Cancer Treatment: An International Society of Paediatric Oncology Supportive Care Consensus Report. JAMA Oncology. 2021; 7:1550-1558.

Merjaneh, N; Young, J; Mangoli, A; Olsen, M; Setty, B; Lane, A; Nagarajan, R; Pressey, JG; Turpin, B. Chemotherapy-induced thrombocytopenia in Ewing sarcoma: Implications and potential for romiplostim supportive care. Pediatric Blood and Cancer. 2021.

Milewski, D; Shukla, S; Gryder, BE; Pradhan, A; Donovan, J; Sudha, P; Vallabh, S; Pyros, A; Xu, Y; Barski, A; et al. FOXF1 is required for the oncogenic properties of PAX3-FOXO1 in rhabdomyosarcoma. Oncogene. 2021; 40:2182-2199.

Miller, TP; DeGroote, NP; Pommert, L; Awoniyi, O; Board, S; Ugboh, N; Joshi, V; Ambrosino, N; Weisnicht, A; Hsiao, H; et al. Comparison of Severe Toxicities Following High Dose Methotrexate Administration By Demographics and over Time in Pediatric Patients with Acute Lymphoblastic Leukemia. Blood. 2021; 138:1970-1970.

Minturn, JE; Mochizuki, AY; Partap, S; Belasco, JB; Lange, BJ; Li, Y; Phillips, PC; Gibbs, IC; Fisher, PG; Fisher, MJ; et al. A Pilot Study of Low-Dose Craniospinal Irradiation in Patients With Newly Diagnosed Average-Risk Medulloblastoma. Frontiers in Oncology. 2021; 11.

Moskop, A; Pommert, L; Thakrar, P; Talano, J; Phelan, R. Chimeric antigen receptor T-cell therapy for marrow and extramedullary relapse of infant acute lymphoblastic leukemia. Pediatric Blood and Cancer. 2021; 68.

Muraleedharan, R; Dasgupta, B. AMPK in the brain: its roles in glucose and neural metabolism. FEBS Journal. 2021.

Muraleedharan, R; Nardini, D; Waclaw, RR; Dasgupta, B. Analysis of reactive astrogliosis in mouse brain using in situ hybridization combined with immunohistochemistry. STAR Protocols. 2021; 2.

Niederkorn, M; Ishikawa, C; M. Hueneman, K; Bartram, J; Stepanchick, E; R. Bennett, J; E. Culver-Cochran, A; Bolanos, LC; Uible, E; Choi, K; et al. The deubiquitinase USP15 modulates cellular redox and is a therapeutic target in acute myeloid leukemia. Leukemia. 2021.

Oatman, N; Dasgupta, N; Arora, P; Choi, K; Gawali, MV; Gupta, N; Parameswaran, S; Salomone, J; Reisz, JA; Lawler, S; et al. Mechanisms of stearoyl CoA desaturase inhibitor sensitivity and acquired resistance in cancer. Science advances. 2021; 7.

Pommert, L; Burns, R; Furumo, Q; Pulakanti, K; Brandt, J; Burke, MJ; Rao, S. Novel germline TRAF3IP3 mutation in a dyad with familial acute B lymphoblastic leukemia. Cancer reports.. 2021; 4.

Pommert, L; Liberio, N; Ng, JS; Egelund, TA; Siver, MJ; Katzenstein, HM; Burke, MJ. Concurrent Imatinib Dosing With High-dose Methotrexate Leads to Acute Kidney Injury and Delayed Methotrexate Clearance in Pediatric Patients With Philadelphia Chromosome-positive B-Cell Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology. 2021; 43:e296-e300.

Pommert, L; Tasian, SK. Chemotherapy Drug Shortages in Pediatric Oncology: A Global Public Health Crisis Threatening Our Children. 2021; 18.

Pullarkat, VA; Lacayo, NJ; Jabbour, E; Rubnitz, JE; Bajel, A; Laetsch, TW; Leonard, J; Colace, SI; Khaw, SL; Fleming, SA; et al. Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma. Cancer Discovery. 2021; 11:1440-1453.

Raskin, S; Angiolillo, AL. Biological and Molecular Markers in the Diagnosis of Childhood Malignancies. In: Wong E; Dietzen D; Bennett M; Haymond S, Ed. Biochemical and Molecular Basis of Pediatric Disease. San Diego CA: Academic Press; 2021.

Raskin, S; Bornhorst, M. Biological Treatments of Neurofibromatosis Type 2 and Other Skull Base Disorders. Otolaryngologic Clinics of North America. 2021; 54:789-801.

Raskin, S; Van Pelt, S; Toner, K; Balakrishnan, PB; Dave, H; Bollard, CM; Yvon, E. Novel TCR-like CAR-T cells targeting an HLA∗0201-restricted SSX2 epitope display strong activity against acute myeloid leukemia. Molecular Therapy - Methods and Clinical Development. 2021; 23:296-306.

Rivas, M; Johnston, ME; Gulati, R; Kumbaji, M; Margues Aguiar, TF; Timchenko, L; Krepischi, A; Shin, S; Bondoc, A; Tiao, G; et al. HDAC1-Dependent Repression of Markers of Hepatocytes and P21 Is Involved in Development of Pediatric Liver Cancer. CMGH Cellular and Molecular Gastroenterology and Hepatology. 2021; 12:1669-1682.

Rubinstein, JD; Jodele, S; Heyenbruch, D; Wilhelm, J; Thomas, S; Lutzko, C; Zhu, X; Leemhuis, T; Cancelas, JA; Keller, M; et al. Off-the-Shelf Third-Party Virus-Specific T Cell Therapy to Treat JC Polyomavirus Infection in Hematopoietic Stem Cell Transplantation Recipients. Transplantation and cellular therapy. 2021.

Rubinstein, JD; Shah, R; Breese, EH; Burns, KC; Mangino, JL; Norris, RE; Lee, L; Mizukawa, B; O'Brien, MM; Phillips, CL; et al. Treatment of posttransplant lymphoproliferative disorder with poor prognostic features in children and young adults: Short-course EPOCH regimens are safe and effective. Pediatric Blood and Cancer. 2021; 68.

Rubinstein, JD; Zhu, X; Leemhuis, T; Pham, G; Ray, L; Emberesh, S; Jodele, S; Thomas, S; Cancelas, JA; Bollard, CM; et al. Virus-specific T cells for adenovirus infection after stem cell transplantation are highly effective and class II HLA restricted. Blood Advances. 2021; 5:3309-3321.

Ruiz-Torres, S; Lambert, PF; Wikenheiser-Brokamp, KA; Wells, SI. Directed differentiation of human pluripotent stem cells into epidermal stem and progenitor cells. Molecular Biology Reports. 2021; 48:6213-6222.

Sabnis, HS; Shulman, DS; Mizukawa, B; Bouvier, N; Zehir, A; Fangusaro, J; Fabrizio, VA; Whitlow, C; Winchester, M; Agresta, L; et al. Multicenter Analysis of Genomically Targeted Single Patient Use Requests for Pediatric Neoplasms. Journal of Clinical Oncology. 2021; 39:3822-3828.

Sabulski, A; Bartlett, AL; Koch, BL; Vatner, R; Mizukawa, B; Phillips, CL. Hyperdiploid Precursor B-acute Lymphoblastic Leukemia Presenting as a Cavernous Sinus Mass in a 4-Year-old Male. Journal of Pediatric Hematology/Oncology. 2021; 43:e494-e497.

Sabulski, A; Bartlett, AL; Koch, BL; Vatner, R; Mizukawa, B; Phillips, CL. Hyperdiploid Precursor B-acute Lymphoblastic Leukemia Presenting as a Cavernous Sinus Mass in a 4-Year-old Male. Journal of Pediatric Hematology/Oncology. 2021; 43:e494-e497.

Sadaf, A; Szabo, S; Ferguson, K; Sorger, JI; Sumegi, J; Bridge, JA; Pressey, JG. Novel ARHGAP23-FER fusion in a metastatic spindle cell-predominant neoplasm with a myofibroblastic phenotype and a sustained metabolic response to lorlatinib. Cancer. 2021; 127:4124-4130.

Sauter, SL; Zhang, X; Romick-Rosendale, L; Wells, SI; Myers, KC; Brusadelli, MG; Poff, CB; Brown, DR; Panicker, G; Unger, ER; et al. Human Papillomavirus Oral- and Sero- Positivity in Fanconi Anemia. Cancers. 2021; 13.

Scheuermann, A; Harker-Murray, P; Pommert, L. Posterior Reversible Encephalopathy Syndrome in the Setting of Asparaginase-associated Pancreatitis in 2 Pediatric Patients With Acute Leukemia. Journal of Pediatric Hematology/Oncology. 2021.

Sertorio, M; Nowrouzi, A; Akbarpour, M; Chetal, K; Salomonis, N; Brons, S; Mascia, A; Ionascu, D; McCauley, S; Kupneski, T; et al. Differential transcriptome response to proton versus X-ray radiation reveals novel candidate targets for combinatorial PT therapy in lymphoma. Radiotherapy and Oncology. 2021; 155:293-303.

Silva de Araujo, BE; Velleuer, E; Dietrich, R; Pomjanski, N; de Santana Almeida Araujo, IK; Schlensog, M; Wells, SI; Dorsman, JC; Schramm, M. Detection of cytogenetic changes and chromosomal aneuploidy with fluorescent in situ hybridization in cytological specimens of oral cancers in Fanconi anemia-Proof of concept. Clinical and Experimental Dental Research. 2021.

Stefanski, KJ; Anixt, JS; Goodman, P; Bowers, K; Leisenring, W; Scott Baker, K; Burns, K; Howell, R; Davies, S; Robison, LL; et al. Long-Term Neurocognitive and Psychosocial Outcomes After Acute Myeloid Leukemia: A Childhood Cancer Survivor Study Report. Journal of the National Cancer Institute. 2021; 113:481-495.

Sung, AJ; Weiss, BD; Sharp, SE; Zhang, B; Trout, AT. Prognostic significance of pretreatment 18F-FDG positron emission tomography/computed tomography in pediatric neuroblastoma. Pediatric Radiology. 2021; 51:1400-1405.

Thapaliya, S; Gilligan, LA; Brady, SL; Anton, CG; Crotty, EJ; Nasser, MP; Geller, JI; Pressey, JG; Zhang, B; Dillman, JR; et al. Comparison of 0.3-mSv CT to Standard-Dose CT for Detection of Lung Nodules in Children and Young Adults With Cancer. American Journal of Roentgenology. 2021; 217:1444-1451.

Thomson, CS; Pundavela, J; Perrino, MR; Coover, RA; Choi, K; Chaney, KE; Rizvi, TA; Largaespada, DA; Ratner, N. WNT5A inhibition alters the malignant peripheral nerve sheath tumor microenvironment and enhances tumor growth. Oncogene. 2021; 40:4229-4241.

Wang, Y; Pandey, RN; Roychoudhury, K; Milewski, D; Kalin, TV; Szabo, S; Pressey, JG; Hegde, RS. Targeting EYA3 in Ewing Sarcoma Retards Tumor Growth and Angiogenesis. Molecular Cancer Therapeutics. 2021; 20:803-815.

Weiss, BD; Wolters, PL; Plotkin, SR; Widemann, BC; Tonsgard, JH; Blakeley, J; Allen, JC; Schorry, E; Korf, B; Robison, NJ; et al. NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas. Journal of Clinical Oncology. 2021; 39:797-806.

Woodruff, TK; Ataman-Millhouse, L; Acharya, KS; Almeida-Santos, T; Anazodo, A; Anderson, RA; Appiah, L; Bader, J; Becktell, K; Brannigan, RE; et al. A View from the past into our collective future: the oncofertility consortium vision statement. Journal of Assisted Reproduction and Genetics. 2021; 38:3-15.

Wright, KD; Yao, X; London, WB; Kao, PC; Gore, L; Hunger, S; Geyer, R; Cohen, KJ; Allen, JC; Katzenstein, HM; et al. A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low-grade glioma. Pediatric Blood and Cancer. 2021; 68.

Wunderlich, M; Manning, N; Sexton, C; O’Brien, E; Byerly, L; Stillwell, C; Perentesis, JP; Mulloy, JC; Mizukawa, B. PD-1 Inhibition Enhances Blinatumomab Response in a UCB/PDX Model of Relapsed Pediatric B-Cell Acute Lymphoblastic Leukemia. Frontiers in Oncology. 2021; 11.

Zalan, A; Maga, T; Perpich, M; Pillay Smiley, N; Weiss McQuaid, S. Parental attitudes regarding the need for genetic services in a pediatric brain tumor survivorship program. Journal of Genetic Counseling. 2021; 30:533-543.

Zhang, Y; Ding, Z; Perentesis, JP; Khuntia, D; Pfister, SX; Sharma, RA. Can Rational Combination of Ultra-high Dose Rate FLASH Radiotherapy with Immunotherapy Provide a Novel Approach to Cancer Treatment?. Comparative Haematology International. 2021; 33:713-722.